Literature DB >> 21840241

Alterations in glutathione S-transferase pi expression following exposure to MPP+ -induced oxidative stress in the blood of Parkinson's disease patients.

Ane Korff1, Brenda Pfeiffer, Michelle Smeyne, Mehmet Kocak, Ronald F Pfeiffer, Richard Jay Smeyne.   

Abstract

The major motor symptoms of Parkinson's disease do not occur until a majority of the dopaminergic neurons in the midbrain SNpc have already died. For this reason, it is critical to identify biomarkers that will allow for the identification of presymptomatic individuals. In this study, we examine the baseline expression of the anti-oxidant protein glutathione S-transferase pi (GSTpi) in the blood of PD patients and environmentally- and age-matched controls and compare it to GSTpi levels following exposure to 1-methyl-4-phenylpyridinium (MPP(+)), an agent that has been shown to induce oxidative stress. We find that after 4 h of exposure to MPP(+), significant increases in GSTpi levels can be observed in the leukocytes of PD patients. No changes were seen in other blood components. This suggests that GSTpi and potentially other members of this and other anti-oxidant families may be viable biomarkers for PD.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21840241      PMCID: PMC3307132          DOI: 10.1016/j.parkreldis.2011.06.026

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  12 in total

1.  Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis.

Authors:  Tiziana Alberio; Alessandra Maria Bossi; Alberto Milli; Elisa Parma; Marzia Bruna Gariboldi; Giovanna Tosi; Leonardo Lopiano; Mauro Fasano
Journal:  FEBS J       Date:  2010-10-26       Impact factor: 5.542

2.  Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta.

Authors:  Justin D Boyd; Haeman Jang; Kennie R Shepherd; Ciaran Faherty; Sally Slack; Yun Jiao; Richard J Smeyne
Journal:  Brain Res       Date:  2007-08-09       Impact factor: 3.252

3.  Glutathione S-transferase polymorphisms and onset age in alpha-synuclein A53T mutant Parkinson's disease.

Authors:  Lawrence I Golbe; Giuseppe Di Iorio; Katerina Markopoulou; Aglaia Athanassiadou; Spiridon Papapetropoulos; Ray L Watts; Jeffery M Vance; Vincenzo Bonifati; Tanishia A Williams; John R Spychala; E Scot Stenroos; Williams G Johnson
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-03-05       Impact factor: 3.568

Review 4.  Glutathione transferases.

Authors:  John D Hayes; Jack U Flanagan; Ian R Jowsey
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

5.  GSTpi expression mediates dopaminergic neuron sensitivity in experimental parkinsonism.

Authors:  Michelle Smeyne; Justin Boyd; Kennie Raviie Shepherd; Yun Jiao; Brooks Barnes Pond; Matthew Hatler; Roland Wolf; Colin Henderson; Richard Jay Smeyne
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

6.  Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease.

Authors:  Alexander J Whitworth; Dorothy A Theodore; Jessica C Greene; Helen Benes; Paul D Wes; Leo J Pallanck
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

Review 7.  Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance.

Authors:  Chun Zhou; Yong Huang; Serge Przedborski
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

8.  Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression.

Authors:  Min Shi; Joshua Bradner; Theo K Bammler; David L Eaton; Jianpeng Zhang; ZuCheng Ye; Angela M Wilson; Thomas J Montine; Catherine Pan; Jing Zhang
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

9.  α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.

Authors:  Kiran Yanamandra; Marina A Gruden; Vida Casaite; Rolandas Meskys; Lars Forsgren; Ludmilla A Morozova-Roche
Journal:  PLoS One       Date:  2011-04-25       Impact factor: 3.240

10.  Proteome analysis of human substantia nigra in Parkinson's disease.

Authors:  Cornelius J Werner; Roland Heyny-von Haussen; Gerhard Mall; Sabine Wolf
Journal:  Proteome Sci       Date:  2008-02-14       Impact factor: 2.480

View more
  5 in total

1.  Zonisamide attenuates MPP+-induced oxidative toxicity through modulation of Ca2+ signaling and caspase-3 activity in neuronal PC12 cells.

Authors:  Vedat Ali Yürekli; Semih Gürler; Mustafa Nazıroğlu; Abdülhadi Cihangir Uğuz; Hasan Rifat Koyuncuoğlu
Journal:  Cell Mol Neurobiol       Date:  2012-11-15       Impact factor: 5.046

Review 2.  Emerging candidate biomarkers for Parkinson's disease: a review.

Authors:  Enrico Saracchi; Silvia Fermi; Laura Brighina
Journal:  Aging Dis       Date:  2013-10-09       Impact factor: 6.745

Review 3.  Glutathione metabolism and Parkinson's disease.

Authors:  Michelle Smeyne; Richard Jay Smeyne
Journal:  Free Radic Biol Med       Date:  2013-05-08       Impact factor: 7.376

Review 4.  Current Challenges Towards the Development of a Blood Test for Parkinson's Disease.

Authors:  Jose A Santiago; Judith A Potashkin
Journal:  Diagnostics (Basel)       Date:  2014-10-22

Review 5.  Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson's Disease Pathogenesis: A Narrative Review.

Authors:  Efthalia Angelopoulou; Yam Nath Paudel; Sokratis G Papageorgiou; Christina Piperi
Journal:  Brain Sci       Date:  2022-01-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.